These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36316124)

  • 1. Reader Response: The Economic Burden of Multiple Sclerosis in the United States: Estimate of Direct and Indirect Costs.
    Vargas WS
    Neurology; 2022 Nov; 99(18):818-819. PubMed ID: 36316124
    [No Abstract]   [Full Text] [Related]  

  • 2. Author Response: The Economic Burden of Multiple Sclerosis in the United States: Estimate of Direct and Indirect Costs.
    Bebo BF
    Neurology; 2022 Nov; 99(18):819. PubMed ID: 36316125
    [No Abstract]   [Full Text] [Related]  

  • 3. The Economic Burden of Multiple Sclerosis in the United States: Estimate of Direct and Indirect Costs.
    Bebo B; Cintina I; LaRocca N; Ritter L; Talente B; Hartung D; Ngorsuraches S; Wallin M; Yang G
    Neurology; 2022 May; 98(18):e1810-e1817. PubMed ID: 35418457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Economic Burden of Vision Loss and Blindness in the United States.
    Rein DB; Wittenborn JS; Zhang P; Sublett F; Lamuda PA; Lundeen EA; Saaddine J
    Ophthalmology; 2022 Apr; 129(4):369-378. PubMed ID: 34560128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic burden of multiple sclerosis in Slovakia - from 2015 to 2020.
    Babela R; Dugas J
    BMC Health Serv Res; 2022 Dec; 22(1):1467. PubMed ID: 36461018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic burden of periodontitis in the United States and Europe: An updated estimation.
    Botelho J; Machado V; Leira Y; Proença L; Chambrone L; Mendes JJ
    J Periodontol; 2022 Mar; 93(3):373-379. PubMed ID: 34053082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The national economic burden of rare disease in the United States in 2019.
    Yang G; Cintina I; Pariser A; Oehrlein E; Sullivan J; Kennedy A
    Orphanet J Rare Dis; 2022 Apr; 17(1):163. PubMed ID: 35414039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost burden of multiple sclerosis in the United States: a systematic review of the literature.
    Adelman G; Rane SG; Villa KF
    J Med Econ; 2013; 16(5):639-47. PubMed ID: 23425293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Economic Burden of Posttraumatic Stress Disorder in the United States From a Societal Perspective.
    Davis LL; Schein J; Cloutier M; Gagnon-Sanschagrin P; Maitland J; Urganus A; Guerin A; Lefebvre P; Houle CR
    J Clin Psychiatry; 2022 Apr; 83(3):. PubMed ID: 35485933
    [No Abstract]   [Full Text] [Related]  

  • 10. The Economic Burden of Schizophrenia in the United States.
    Kadakia A; Catillon M; Fan Q; Williams GR; Marden JR; Anderson A; Kirson N; Dembek C
    J Clin Psychiatry; 2022 Oct; 83(6):. PubMed ID: 36244006
    [No Abstract]   [Full Text] [Related]  

  • 11. ECONOMIC BURDEN OF MULTIPLE SCLEROSIS IN GEORGIA.
    Gugutsidze D; Gigineishvili D; Kiziria M; Vashadze T; Tsiskaridze A; Shakarishvili R
    Georgian Med News; 2022 Jan; (322):167-170. PubMed ID: 35134781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct, indirect and intangible costs of acute hand and wrist injuries: A systematic review.
    Robinson LS; Sarkies M; Brown T; O'Brien L
    Injury; 2016 Dec; 47(12):2614-2626. PubMed ID: 27751502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple sclerosis: Frequency, cost, and economic burden in the United States.
    Chen AY; Chonghasawat AO; Leadholm KL
    J Clin Neurosci; 2017 Nov; 45():180-186. PubMed ID: 28676312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The economic burden of major adult visual disorders in the United States.
    Rein DB; Zhang P; Wirth KE; Lee PP; Hoerger TJ; McCall N; Klein R; Tielsch JM; Vijan S; Saaddine J
    Arch Ophthalmol; 2006 Dec; 124(12):1754-60. PubMed ID: 17159036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An update on the economic burden of type 2 diabetes mellitus in China.
    Ding C; Bao Y; Bai B; Liu X; Shi B; Tian L
    Expert Rev Pharmacoecon Outcomes Res; 2022 Jun; 22(4):617-625. PubMed ID: 34937503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Financial Toxicity in Atherosclerotic Cardiovascular Disease in the United States: Current State and Future Directions.
    Khera R; Valero-Elizondo J; Nasir K
    J Am Heart Assoc; 2020 Oct; 9(19):e017793. PubMed ID: 32924728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost of disorders of the brain in Europe 2010.
    Gustavsson A; Svensson M; Jacobi F; Allgulander C; Alonso J; Beghi E; Dodel R; Ekman M; Faravelli C; Fratiglioni L; Gannon B; Jones DH; Jennum P; Jordanova A; Jönsson L; Karampampa K; Knapp M; Kobelt G; Kurth T; Lieb R; Linde M; Ljungcrantz C; Maercker A; Melin B; Moscarelli M; Musayev A; Norwood F; Preisig M; Pugliatti M; Rehm J; Salvador-Carulla L; Schlehofer B; Simon R; Steinhausen HC; Stovner LJ; Vallat JM; Van den Bergh P; van Os J; Vos P; Xu W; Wittchen HU; Jönsson B; Olesen J;
    Eur Neuropsychopharmacol; 2011 Oct; 21(10):718-79. PubMed ID: 21924589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multiple sclerosis: cost of the illness].
    Tissot E; Woronoff-Lemsi MC
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):1169-74. PubMed ID: 11787352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A literature review of cost-of-illness studies on the economic burden of multiple sclerosis.
    Paz-Zulueta M; Parás-Bravo P; Cantarero-Prieto D; Blázquez-Fernández C; Oterino-Durán A
    Mult Scler Relat Disord; 2020 Aug; 43():102162. PubMed ID: 32442885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of economic burden of fatigue in adults with multiple sclerosis: An analysis of US National Health and Wellness Survey data.
    Le HH; Ken-Opurum J; LaPrade A; Maculaitis MC; Sheehan JJ
    Mult Scler Relat Disord; 2022 Sep; 65():103971. PubMed ID: 35843012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.